Applied DNA Sciences, Inc. (BNBX) — Cash Flow-to-Debt Ratio
Applied DNA Sciences, Inc. (BNBX) has a Cash Flow-to-Debt Ratio of -2.48x as of December 2025, meaning its operating cash flow of $-5.55 Million could theoretically repay -2% of its total liabilities ($2.24 Million) in one year. See working capital to net assets of Applied DNA Sciences, Inc. to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Applied DNA Sciences, Inc. Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Applied DNA Sciences, Inc. across 5 annual periods. Also explore BNBX year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Applied DNA Sciences, Inc. (2021–2025)
Year-by-year debt coverage analysis for Applied DNA Sciences, Inc.. For market capitalisation and broader financial context, see Applied DNA Sciences, Inc. market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.02x | $-12.52 Million | $2.50 Million | ▼ -39.8% |
| 2024 | -3.59x | $-13.71 Million | $3.82 Million | ▼ -406.7% |
| 2023 | -0.71x | $-6.22 Million | $8.78 Million | ▲ +26.2% |
| 2022 | -0.96x | $-8.98 Million | $9.36 Million | ▲ +76.3% |
| 2021 | -4.05x | $-13.39 Million | $3.30 Million | — |